Skip to main content

Want a detailed portfolio tracker?

Performance analysis of ZyVersa Therapeutics (ZVSA)

Annual Return

Over the past 3 years, ZVSA has had an average annual return of -91.13%, underperforming the benchmark SPY, which returned +22.45% annual.

Since Dec 12, 2022, ZVSA has had an average annual return of -97.14%, underperforming the benchmark SPY, which returned +21.73% annual.

2025202420232022
+0%-90.91%-98.42%-93.02%

Monthly Return

YearJanFebMarAprMayJunJulAugSepOctNovDecAnnually Total
2025+100%-50.00%+0%+0%+0%+0%+0%+0%
2024-36.36%+100%-28.57%-30.00%-14.29%-16.67%-20.00%+0%-25.00%+0%-66.67%+0%-90.91%
2023+17.19%+19.56%-12.27%-75.99%-20.87%-33.13%-29.36%-18.18%-7.94%-36.21%-21.62%-62.07%-98.42%
2022-93.02%-93.02%

Drawdown analysis of ZyVersa Therapeutics (ZVSA)

The maximum drawdown for the ZVSA was -99.99%, occurring on Nov 14, 2024. This drawdown has not yet recovered.

The current ZVSA drawdown is -99.99%.

Since Dec 12, 2022 ZVSA has experienced the following drawdowns:

  • 50% or more: 1 time
  • 40% or more: 1 time
  • 30% or more: 1 time
  • 20% or more: 1 time
  • 10% or more: 1 time
DepthStartTo BottomBottomTo RecoverEndTotal
-99.99%Dec 12, 2022484Nov 14, 2024OngoingOngoingOngoing